Analytical Data
-
基因名
DIPA
- Application
-
别名
Delta-interacting protein A; DIPA; Hepatitis delta antigen interacting protein A; Hepatitis delta antigen-interacting protein A
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q15834
-
表达区间
1-202aa
-
氨基酸序列
MEAEAGGLEE LTDEEMAALG KEELVRRLRR EEAARLAALV QRGRLMQEVN RQLQGHLGEI RELKQLNRRL QAENRELRDL CCFLDSERQR GRRAARQWQL FGTQASRAVR EDLGGCWQKL AELEGRQEEL LRENLALKEL CLALGEEWGP RGGPSGAGGS GAGPAPELAL PPCGPRDLGD GSSSTGSVGS PDQLPLACSP DD
-
分子量
22 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
DIPA (Diacylglycerol Acyltransferase-1 Interacting Protein A) is a newly identified protein involved in lipid metabolism and cellular processes. The importance of DIPA has been underscored by its association with various metabolic disorders, including obesity, diabetes, and cardiovascular diseases. Recent studies suggest that DIPA plays a crucial role in the regulation of diacylglycerol (DAG) levels, which are critical mediators of cellular signaling pathways. Understanding the structure and function of DIPA is essential for elucidating its role in health and disease. Researchers are focusing on the recombinant production of DIPA to investigate its biological functions and potential as a therapeutic target. By utilizing recombinant DNA technology, scientists can produce large quantities of DIPA for in vitro studies, allowing for detailed analysis of its interactions with other proteins and cellular components. This research holds promise for identifying novel targets for drug development aimed at treating metabolic diseases. Furthermore, the characterization of DIPA's structure may reveal insights into its mechanism of action and how it influences lipid homeostasis. As the obesity epidemic continues to rise globally, understanding the underlying molecular mechanisms involving proteins like DIPA is increasingly critical for developing effective therapeutic interventions.
